Theo H. van der Kwast

FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy

T. H. van der Kwast, E. Zwarthoff, I. Lurkin, 2010, PloS one.